Molecular markers as indicators of antimalarial drug failure rates

Tropical Medicine and International Health

Volumn 12, Issue 11, 2007, Pages 1298-1301

  Hastings, Ian M ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Drug resistance; GFI; GRI; Malaria; Molecular markers

Indexed keywords

ANTIMALARIAL AGENT; INDICATOR; MOLECULAR MARKER;

ANTIMALARIAL AGENT; BIOINDICATOR; DRUG; DRUG RESISTANCE; MOLECULAR ANALYSIS; MUTATION; PROTOZOAN;

BLOOD SAMPLING; CLINICAL STUDY; GENETICS; GENOTYPE; HUMAN; MALARIA; MATHEMATICS; MUTATION; PARASITOLOGY; PLASMODIUM FALCIPARUM; POPULATION; PREVALENCE; REVIEW; TREATMENT FAILURE;

ANIMALS; ANTIMALARIALS; BIOLOGICAL MARKERS; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 36549048017     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2007.01928.x     Document Type: Review

References (17)

1. Djimde A, Doumbo OK, Steketee RW Plowe CV (2001a) Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358, 890 891.
2. Djimde A, Doumbo OK, Cortese JF et al. (2001b) A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine 344, 257 263.
3. Djimde AA, Dolo A, Ouattara A et al. (2004) Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. Journal of Infectious Diseases 190, 853 855.
4. Gregson A Plowe CV (2005) Mechanisms of resistance of malaria parasites to antifolates. Pharmacological Reviews 57, 117 145.
5. International Artemisinin Study Group (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363, 9 17.
6. Kublin JG, Dzinjalamala FK, Kamwendo DD et al. (2002) Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Journal of Infectious Diseases 185, 380 388.
7. Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ Dorsey G (2003) Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. American Journal of Tropical Medicine and Hygiene 69, 247 252.
8. Mockenhaupt FP, Ehrhardt S, Eggelte TA et al. (2005) Chloroquine- treatment failure in northern Ghana: roles of pfcrt T76 and pfmdr1 Y86. Annals of Tropical Medicine and Parasitology 99, 723 732.
9. Mugittu K, Ndejembi M, Malisa A et al. (2004) Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance. American Journal of Tropical Medicine and Hygiene 71, 696 702.
10. Plowe CV (2003) Monitoring antimalarial drug resistance: making the most of the tools at hand. Journal of Experimental Biology 206, 3745 3752.
11. Plowe CV, Cortese JF, Djimde A et al. (1997) Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. Journal of Infectious Diseases 176, 1590 1596.
12. Sibley CH, Hyde JE, Sims PFG et al. (2001) Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology 17, 582 588.
13. Talisuna AO, Bloland P D'Alessandro U (2004) History, dynamics, and public health importance of malaria parasite resistance. Clinical Microbiology Reviews 17, 235 254.
14. Tinto H, Sanou B, Dujardin JC et al. (2005) Short report: usefulness of the Plasmodium falciparum chloroquine resistance transporter T76 genotype failure index for the estimation of in vivo chloroquine resistance in Burkina Faso. American Journal of Tropical Medicine and Hygiene 73, 171 173.
15. Trape JF, Pison G, Preziosi MP et al. (1998) Impact of chloroquine resistance on malaria mortality. Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences 321, 689 697.
16. World Health Organization (2005) Susceptibility of Plasmodium falciparum to Antimalarial Drugs: Report on Global Monitoring 1996-2004. WHO, Geneva.
17. World Health Organization (2006) Guidelines for the Treatment of Malaria - Report (http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf). Geneva, Switzerland.